CpG methylation potentiates pixantrone and doxorubicin-induced DNA damage and is a marker of drug sensitivity

Nucleic Acids Research

Volumn 37, Issue 19, 2009, Pages 6355-6370

  Evison, Benny J ^a   Bilardi, Rebecca A ^a   Chiu, Francis C K ^b   Pezzoni, Gabriella ^c   Phillips, Don R ^a   Cutts, Suzanne M ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Cell Therapeutics Europe   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOSINE; DOXORUBICIN; FORMALDEHYDE; PIXANTRONE;

ARTICLE; CELL STRAIN HCT116; COLON CANCER; CONTROLLED STUDY; COVALENT BOND; CPG ISLAND; DNA ADDUCT; DNA ALKYLATION; DNA DAMAGE; DNA METHYLATION; DRUG DNA BINDING; DRUG SENSITIVITY; GENETIC MARKER; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; PRIORITY JOURNAL; WILD TYPE;

5-METHYLCYTOSINE; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; CPG ISLANDS; DNA ADDUCTS; DNA DAMAGE; DNA METHYLATION; DNA-CYTOSINE METHYLASES; DOXORUBICIN; FORMALDEHYDE; HUMANS; ISOQUINOLINES; MASS SPECTROMETRY;

MAMMALIA;

EID: 71049191384     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp700     Document Type: Article

References (69)

1. Faulds,D., Balfour,J.A., Chrisp,P. and Langtry,H.D. (1991) Mitoxantrone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the chemotherapy of cancer. Drugs, 41 400-449.
2. Hazlehurst,L.A., Krapcho,A.P. and Hacker,M.P. (1995) Correlation of DNA reactivity and cytotoxicity of a new class of anticancer agents: aza-anthracenediones. Cancer Lett., 91, 115-124.
3. De Isabella,P., Palumbo,M., Sissi,C., Capranico,G., Carenini,N., Menta,E., Oliva,A., Spinelli,S., Krapcho,A.P., Giuliani,F.C. et al. (1995) Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives. Mol. Pharmacol., 48 30-38.
4. Hazlehurst,L.A., Krapcho,A.P. and Hacker,M.P. (1995) Comparison of aza-anthracenedione-induced DNA damage and cytotoxicity in experimental tumor cells. Biochem. Pharmacol., 50, 1087-1094.
5. Zwelling,L.A., Mayes,J., Altschuler,E., Satitpunwaycha,P., Tritton,T.R. and Hacker,M.P. (1993) Activity of two novel anthracene-9,10-diones against human leukemia cells containing intercalator-sensitive or -resistant forms of topoisomerase II. Biochem. Pharmacol., 46 265-271.
6. Evison,B.J., Mansour,O.C., Menta,E., Phillips,D.R. and Cutts,S.M. (2007) Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent. Nucleic Acids Res., 35, 3581-3589.
7. Evison,B.J., Chiu,F., Pezzoni,G., Phillips,D.R. and Cutts,S.M. (2008) Formaldehyde-activated Pixantrone is a monofunctional DNA alkylator that binds selectively to CpG and CpA doublets. Mol. Pharmacol., 74 184-194.
8. Laird,P.W. (2003) The power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3, 253-266.
9. Millard,J.T. and Beachy,T.M. (1993) Cytosine methylation enhances mitomycin C cross-linking. Biochemistry, 32, 12850-12856.
10. Robertson,K.D. and Wolffe,A.P. (2000) DNA methylation in health and disease. Nat. Rev. Genet., 1, 11-19.
11. Jones,P.A. and Baylin,S.B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
12. Momparler,R.L. and Bovenzi,V. (2000) DNA methylation and cancer. J. Cell Physiol., 183, 145-154.
13. Melki,J.R., Vincent,P.C. and Clark,S.J. (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res., 59, 3730-3740.
14. Santos,K.F., Mazzola,T.N. and Carvalho,H.F. (2005) The prima donna of epigenetics: The regulation of gene expression by DNA methylation. Braz. J. Med. Biol. Res., 38, 1531-1541.
15. Esteller,M. (2002) CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene, 21, 5427-5440.
16. Esteller,M., Corn,P.G., Baylin,S.B. and Herman,J.G. (2001) A gene hypermethylation profile of human cancer. Cancer Res., 61, 3225-3229.
17. Esteller,M. (2007) Epigenetic gene silencing in cancer: The DNA hypermethylome. Hum. Mol. Genet., 16(Spec No 1), R50-R59.
18. Costello,J.F., Fruhwald,M.C., Smiraglia,D.J., Rush,L.J., Robertson,G.P., Gao,X., Wright,F.A., Feramisco,J.D., Peltomaki,P., Lang,J.C. et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24, 132-138.
19. Paz,M.F., Fraga,M.F., Avila,S., Guo,M., Pollan,M., Herman,J.G. and Esteller,M. (2003) A systematic profile of DNA methylation in human cancer cell lines. Cancer Res., 63, 1114-1121.
20. Shen,L., Kondo,Y., Ahmed,S., Boumber,Y., Konishi,K., Guo,Y., Chen,X., Vilaythong,J.N. and Issa,J.P. (2007) Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel. Cancer Res., 67, 11335-11343.
21. Li,V.S., Reed,M., Zheng,Y., Kohn,H. and Tang,M. (2000) C5 cytosine methylation at CpG sites enhances sequence selectivity of mitomycin C-DNA bonding. Biochemistry, 39, 2612-2618.
22. Wallace,R.B. and Miyada,C.G. (1987) Oligonucleotide probes for the screening of recombinant DNA libraries. Methods Enzymol., 152 432-442.
23. Herman,J.G. (1999) Hypermethylation of tumor suppressor genes in cancer. Semin. Cancer Biol., 9, 359-367.
24. Yoon,J.H., Smith,L.E., Feng,Z., Tang,M., Lee,C.S. and Pfeifer,G.P. (2001) Methylated CpG dinucleotides are the preferential targets for G-to-T transversion mutations induced by benzo[a]pyrene diol epoxide in mammalian cells: Similarities with the p53 mutation spectrum in smoking-associated lung cancers. Cancer Res., 61, 7110-7117.
25. Mathur,P., Xu,J. and Dedon,P.C. (1997) Cytosine methylation enhances DNA damage produced by groove binding and intercalating enediynes: Studies with esperamicins A1 and C. Biochemistry, 36, 14868-14873.
26. Baylin,S.B., Herman,J.G., Graff,J.R., Vertino,P.M. and Issa,J.P. (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196.
27. Bird,A.P. (1986) CpG-rich islands and the function of DNA methylation. Nature, 321, 209-213.
28. Mathison,B.H., Said,B. and Shank,R.C. (1993) Effect of 5-methylcytosine as a neighboring base on methylation of DNA guanine by N-methyl-N-nitrosourea. Carcinogenesis, 14, 323-327.
29. Pfeifer,G.P., Drouin,R., Riggs,A.D. and Holmquist,G.P. (1991) In vivo mapping of a DNA adduct at nucleotide resolution: Detection of pyrimidine (6-4) pyrimidone photoproducts by ligation-mediated polymerase chain reaction. Proc. Natl Acad. Sci. USA, 88, 1374-1378.
30. Glickman,B.W., Schaaper,R.M., Haseltine,W.A., Dunn,R.L. and Brash,D.E. (1986) The C-C (6-4) UV photoproduct is mutagenic in Escherichia coli. Proc. Natl Acad. Sci. USA, 83, 6945-6949.
31. Denissenko,M.F., Chen,J.X., Tang,M.S. and Pfeifer,G.P. (1997) Cytosine methylation determines hot spots of DNA damage in the human P53 gene. Proc. Natl Acad. Sci. USA, 94, 3893-3898.
32. Tang,M.S., Zheng,J.B., Denissenko,M.F., Pfeifer,G.P. and Zheng,Y. (1999) Use of UvrABC nuclease to quantify benzo[a]pyrene diol epoxide-DNA adduct formation at methylated versus unmethylated CpG sites in the p53 gene. Carcinogenesis, 20, 1085-1089.
33. Chen,J.X., Zheng,Y., West,M. and Tang,M.S. (1998) Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots. Cancer Res., 58, 2070-2075.
34. Johnson,W.S., He,Q.Y. and Tomasz,M. (1995) Selective recognition of the m5CpG dinucleotide sequence in DNA by mitomycin C for alkylation and cross-linking. Bioorg. Med. Chem., 3, 851-860.
35. Parker,B.S., Cutts,S.M. and Phillips,D.R. (2001) Cytosine methylation enhances mitoxantrone-DNA adduct formation at CpG dinucleotides. J. Biol. Chem., 276, 15953-15960.
36. Parker,B.S., Buley,T., Evison,B.J., Cutts,S.M., Neumann,G.M., Iskander,M.N. and Phillips,D.R. (2004) A molecular understanding of mitoxantrone-DNA adduct formation: Effect of cytosine methylation and flanking sequences. J. Biol. Chem., 279, 18814-18823.
37. Cullinane,C., van Rosmalen,A. and Phillips,D.R. (1994) Does adriamycin induce interstrand cross-links in DNA? Biochemistry, 33, 4632-4638.
38. Cullinane,C. and Phillips,D.R. (1990) Induction of stable transcriptional blockage sites by adriamycin: GpC specificity of apparent adriamycin-DNA adducts and dependence on iron(III) ions. Biochemistry, 29, 5638-5646.
39. Luce,R.A., Sigurdsson,S.T. and Hopkins,P.B. (1999) Quantification of formaldehyde-mediated covalent adducts of adriamycin with DNA. Biochemistry, 38, 8682-8690.
40. Taatjes,D.J., Gaudiano,G., Resing,K. and Koch,T.H. (1996) Alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin. J. Med. Chem., 39, 4135-4138.
41. Wang,A.H., Ughetto,G., Quigley,G.J. and Rich,A. (1987) Interactions between an anthracycline antibiotic and DNA: Molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution. Biochemistry, 26, 1152-1163.
42. Chen,K.S., Gresh,N. and Pullman,B. (1986) A theoretical investigation on the sequence selective binding of adriamycin to double-stranded polynucleotides. Nucleic Acids Res., 14, 2251-2267.
43. Das,A., Tang,K.S., Gopalakrishnan,S., Waring,M.J. and Tomasz,M. (1999) Reactivity of guanine at m5CpG steps in DNA: Evidence for electronic effects transmitted through the base pairs. Chem. Biol., 6, 461-471.
44. Hodges-Garcia,Y. and Hagerman,P.J. (1992) Cytosine methylation can induce local distortions in the structure of duplex DNA. Biochemistry 31, 7595-7599.
45. Zacharias,W., Jaworski,A. and Wells,R.D. (1990) Cytosine methylation enhances Z-DNA formation in vivo. J. Bacteriol., 172, 3278-3283.
46. Klysik,J., Stirdivant,S.M., Singleton,C.K., Zacharias,W. and Wells,R.D. (1983) Effects of 5 cytosine methylation on the B-Z transition in DNA restriction fragments and recombinant plasmids. J. Mol. Biol., 168, 51-71.
47. Zingg,J.M. and Jones,P.A. (1997) Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis. Carcinogenesis, 18, 869-882.
48. Hodges-Garcia,Y. and Hagerman,P.J. (1995) Investigation of the influence of cytosine methylation on DNA flexibility. J. Biol. Chem., 270 197-201.
49. Vargason,J.M., Eichman,B.F. and Ho,P.S. (2000) The extended and eccentric E-DNA structure induced by cytosine methylation or bromination. Nat. Struct. Biol., 7, 758-761.
50. Kumar,G.S., He,Q.Y., Behr-Ventura,D. and Tomasz,M. (1995) Binding of 2,7-diaminomitosene to DNA: Model for the precovalent recognition of DNA by activated mitomycin C. Biochemistry, 34, 2662-2671.
51. Geacintov,N.E., Shahbaz,M., Ibanez,V., Moussaoui,K. and Harvey,R.G. (1988) Base-sequence dependence of noncovalent complex formation and reactivity of benzo[a]pyrene diol epoxide with polynucleotides. Biochemistry, 27, 8380-8387.
52. Stresemann,C., Brueckner,B., Musch,T., Stopper,H. and Lyko,F. (2006) Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res., 66, 2794-2800.
53. Brueckner,B., Boy,R.G., Siedlecki,P., Musch,T., Kliem,H.C., Zielenkiewicz,P., Suhai,S., Wiessler,M. and Lyko,F. (2005) Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Res., 65, 6305-6311.
54. Brueckner,B. and Lyko,F. (2004) DNA methyltransferase inhibitors: Old and new drugs for an epigenetic cancer therapy. Trends Pharmacol. Sci., 25, 551-554.
55. Villar-Garea,A., Fraga,M.F., Espada,J. and Esteller,M. (2003) Procaine is a DNA-demethylating agent with growth-inhibitory effects in human cancer cells. Cancer Res., 63, 4984-4989.
56. Lee,B.H., Yegnasubramanian,S., Lin,X. and Nelson,W.G. (2005) Procainamide is a specific inhibitor of DNA methyltransferase 1. J. Biol. Chem., 280, 40749-40756.
57. Lin,X., Asgari,K., Putzi,M.J., Gage,W.R., Yu,X., Cornblatt,B.S., Kumar,A., Piantadosi,S., DeWeese,T.L., De Marzo,A.M. et al. (2001) Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res., 61 8611-8616.
58. Parker,B.S., Cutts,S.M., Nudelman,A., Rephaeli,A., Phillips,D.R. and Sukumar,S. (2003) Mitoxantrone mediates demethylation and reexpression of cyclin d2, estrogen receptor and 14.3.3sigma in breast cancer cells. Cancer Biol. Ther., 2, 259-263.
59. Pfeifer,G.P., Grunberger,D. and Drahovsky,D. (1984) Impaired enzymatic methylation of BPDE-modified DNA. Carcinogenesis, 5, 931-935.
60. Wojciechowski,M.F. and Meehan,T. (1984) Inhibition of DNA methyltransferases in vitro by benzo[a]pyrene diol epoxide-modified substrates. J. Biol. Chem., 259, 9711-9716.
61. Subach,O.M., Baskunov,V.B., Darii,M.V., Maltseva,D.V., Alexandrov,D.A., Kirsanova,O.V., Kolbanovskiy,A., Kolbanovskiy,M., Johnson,F., Bonala,R. et al. (2006) Impact of benzo[a]pyrene-2′-deoxyguanosine lesions on methylation of DNA by SssI and HhaI DNA methyltransferases. Biochemistry, 45, 6142-6159.
62. Wilson,V.L. and Jones,P.A. (1983) Inhibition of DNA methylation by chemical carcinogens in vitro. Cell, 32, 239-246.
63. Wilson,V.L. and Jones,P.A. (1984) Chemical carcinogen-mediated decreases in DNA 5-methylcytosine content of BALB/3T3 cells. Carcinogenesis, 5, 1027-1031.
64. Sadikovic,B. and Rodenhiser,D.I. (2006) Benzopyrene exposure disrupts DNA methylation and growth dynamics in breast cancer cells. Toxicol. Appl. Pharmacol., 216, 458-468.
65. Hockley,S.L., Arlt,V.M., Brewer,D., Giddings,I. and Phillips,D.H. (2006) Time- and concentration-dependent changes in gene expression induced by benzo(a)pyrene in two human cell lines, MCF-7 and HepG2. BMC Genomics 7, 260.
66. Coldwell,K.E., Cutts,S.M., Ognibene,T.J., Henderson,P.T. and Phillips,D.R. (2008) Detection of Adriamycin-DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations. Nucleic Acids Res., 36, e100.
67. Spanel,P., Smith,D., Holland,T.A., Al Singary,W. and Elder,J.B. (1999) Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. Rapid Commun. Mass Spectrom., 13, 1354-1359.
68. Kato,S., Burke,P.J., Koch,T.H. and Bierbaum,V.M. (2001) Formaldehyde in human cancer cells: Detection by preconcentration-chemical ionization mass spectrometry. Anal. Chem., 73, 2992-2997.
69. Rhee,I., Bachman,K.E., Park,B.H., Jair,K.W., Yen,R.W., Schuebel,K.E., Cui,H., Feinberg,A.P., Lengauer,C., Kinzler,K.W. et al. (2002) DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416, 552-556.